- Home
- KROS vs ISD Comparison
KROS vs ISD Comparison
Compare KROS & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ISD
- Stock Information
- Founded
- KROS 2015
- ISD 2012
- Country
- KROS United States
- ISD United States
- Employees
- KROS N/A
- ISD N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ISD Trusts Except Educational Religious and Charitable
- Sector
- KROS Health Care
- ISD Finance
- Exchange
- KROS Nasdaq
- ISD Nasdaq
- Market Cap
- KROS 565.0M
- ISD 472.3M
- IPO Year
- KROS 2020
- ISD N/A
- Fundamental
- Price
- KROS $15.66
- ISD $14.54
- Analyst Decision
- KROS Buy
- ISD
- Analyst Count
- KROS 14
- ISD 0
- Target Price
- KROS $20.56
- ISD N/A
- AVG Volume (30 Days)
- KROS 430.7K
- ISD 127.1K
- Earning Date
- KROS 11-05-2025
- ISD 01-01-0001
- Dividend Yield
- KROS N/A
- ISD 9.69%
- EPS Growth
- KROS N/A
- ISD N/A
- EPS
- KROS 0.47
- ISD N/A
- Revenue
- KROS $232,844,000.00
- ISD N/A
- Revenue This Year
- KROS $5,579.44
- ISD N/A
- Revenue Next Year
- KROS N/A
- ISD N/A
- P/E Ratio
- KROS $33.65
- ISD N/A
- Revenue Growth
- KROS 85820.30
- ISD N/A
- 52 Week Low
- KROS $9.12
- ISD $10.98
- 52 Week High
- KROS $72.37
- ISD $13.17
- Technical
- Relative Strength Index (RSI)
- KROS 59.38
- ISD 53.73
- Support Level
- KROS $15.23
- ISD $14.44
- Resistance Level
- KROS $15.85
- ISD $14.67
- Average True Range (ATR)
- KROS 0.52
- ISD 0.08
- MACD
- KROS 0.01
- ISD -0.02
- Stochastic Oscillator
- KROS 72.91
- ISD 39.58
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.